BMI View: Despite its high growth potential, the African region as a whole is unlikely to attract substantial investment from foreign pharmaceutical firms due to low pharmaceutical and healthcare spending in many African nations. For Cameroon in particular, we believe that there must be significant economic improvement before the country will see higher pharmaceutical and healthcare spending. Headline Expenditure Projections ? Pharmaceuticals: XAF131.4bn (US$260mn) in 2012 to XAF148.8bn (US$300mn) in 2013; +13.3% in local currency terms and +15.3% in US dollar terms. Forecast broadly in line with Q413. ? Healthcare: XAF689.7bn (US$1.4bn) in 2012 to XAF741.8bn (US$1.5bn) in 2013; +7.5% …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131559.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cameroon-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.
No comments:
Post a Comment